Mycotoxins’ Activity at Toxic and Sub-Toxic Concentrations: Differential Cytotoxic and Genotoxic Effects of Single and Combined Administration of Sterigmatocystin, Ochratoxin A and Citrinin on the Hepatocellular Cancer Cell Line Hep3B

Nikolia Αnninou, Ekaterini Chatzaki, Fotini Papachristou, Μichail Pitiakoudis and Constantinos Simopoulos
Additional contact information
Nikolia Αnninou: Cell Culture Unit, Laboratory of Experimental Surgery and Surgical Research, Medical School, Democritus University of Thrace, Alexandroupolis 68100, Greece
Ekaterini Chatzaki: Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupolis 68100, Greece
Fotini Papachristou: Cell Culture Unit, Laboratory of Experimental Surgery and Surgical Research, Medical School, Democritus University of Thrace, Alexandroupolis 68100, Greece
Μichail Pitiakoudis: Surgical Department, University General Hospital of Alexandroupolis, Medical School, Democritus University of Thrace, Alexandroupolis 68100, Greece
Constantinos Simopoulos: Cell Culture Unit, Laboratory of Experimental Surgery and Surgical Research, Medical School, Democritus University of Thrace, Alexandroupolis 68100, Greece

IJERPH, 2014, vol. 11, issue 2, 1-18

Abstract: Food safety organizations indicate the likelihood of constant human and animal exposure to mycotoxin mixtures as a possible negative public health impact. Risk assessment demonstrates that certain mycotoxins of Aspergillus and Penicillium spp. are toxic and hold a significant genotoxic efficacy at nanomolar concentrations. The aim of the current study was to investigate the potential cytogenetic effects of sterigmatocystin (STER), ochratoxin A (OTA) and citrinin (CTN) alone or in combination, at pM to ?? concentrations, on the human hepatocellular cancer cell line Hep3B. MTT reduction, mitotic divisions, cell cycle delays and sister chromatid exchange rates (SCE) were determined as endpoints of metabolic activity, cytotoxicity, cytostaticity, and genotoxicity, respectively. All mycotoxin treatments induce SCE rates from 10 ? 12 M, while their cytotoxic and cytostatic potential varies. In PRI and MI assays, but not at MTT, STER alone or in combination with OTA + CTN appeared cytostatic and cytotoxic, even at 10 ?12 M, while CTN alone and all other combinations displayed substantial cellular survival inhibition in doses ? 10 ?8 M. Co-administration of STER + OTA or STER + CTN in concentrations ? 10 ?1 M, increased the MI and MTT activity, while it did not affect the PRI. Mycotoxin co-treatments revealed in general similar-to-additive or antagonistic genotoxic and cytotoxic effects. Our results for the first time describe that STER alone or in combination with OTA and/or CTN share a cytotoxic and cytogenetic potential even at picoMolar concentrations on human hepatoma cells in vitro .

Keywords: sterigmatocystin; ochratoxin A; citrinin; metabolic activity; genotoxicity; cytostaticity; cytotoxicity; picoMolar concentrations (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2014
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/11/2/1855/pdf (application/pdf)
https://www.mdpi.com/1660-4601/11/2/1855/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:11:y:2014:i:2:p:1855-1872:d:32750

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().